{"nct_id":"NCT06158854","title":"A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion","status":"RECRUITING","status_verified_date":"2025-04","start_date":"2024-04-01","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2028-02","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["ABBV"]}